Results 171 to 180 of about 17,163 (245)

Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]

open access: yesSci Rep
Hecker DJ   +11 more
europepmc   +1 more source

Rate of Hearing Loss in Platinum-Naïve Patients Receiving Immune Checkpoint Inhibitors. [PDF]

open access: yesOtolaryngol Head Neck Surg
Brooks KA   +11 more
europepmc   +1 more source

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]

open access: yesHematol Rep
Peláez Casillas N   +4 more
europepmc   +1 more source

Eleutheroside E alleviates cisplatin-induced ototoxicity by down-regulating MAPK/NF-κB/NLRP3 signaling pathway and inhibiting cochlear cell pyroptosis. [PDF]

open access: yesCommun Biol
Zhang Y   +12 more
europepmc   +1 more source

Navigating the Genetic Risk of Chemotherapy-Induced Hearing Loss in the Stria Vascularis. [PDF]

open access: yesClin Pharmacol Ther
Lazetic T   +4 more
europepmc   +1 more source

Hearing Characteristics of Adults before Exposure to Potentially Ototoxic Chemotherapy. [PDF]

open access: yesInt Arch Otorhinolaryngol
Peruch CV   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy